Abstract:There is abundant evidence that the dopamine (DA) neurons that project to the nucleus accumbens play a central role in neurobiological mechanisms underpinning drug dependence. This chapter considers the ways in which these projections facilitate the addiction to nicotine and tobacco. It focuses on the complimentary roles of the two principal subdivisions of the nucleus accumbens, the accumbal core and shell, in the acquisition and maintenance of nicotine-seeking behavior. The ways in which tonic and phasic fir… Show more
“…There is abundant evidence that the reinforcing properties of nicotine depend upon stimulation of DA neurones in the ventral tegmental area that project to the nucleus accumbens (see Balfour 2015 for review). The ability of psychostimulant drugs, such as nicotine, to serve as reinforcers in selfadministration experiments have been particularly related to increased DA release in the shell subdivision of the accumbens.…”
Section: The Role Of Mglur5 Receptors In the Neural Responses To Nicomentioning
confidence: 99%
“…Thus, it seems likely that, while the addiction to tobacco smoke requires the presence of nicotine, other components of tobacco smoke also contribute significantly to the addiction (Balfour 2015). Although there are a number of chemical components within tobacco smoke that may enhance the addictive properties of nicotine, much attention has been focused on the role of sensory stimuli within the smoke in the development of dependence.…”
Section: Mglur5 Receptors and Models Of Relapsementioning
confidence: 99%
“…Repetitive non-contingent daily injections of nicotine result in sensitisation of the locomotor stimulation evoked by the drug. However, there is evidence that two mechanisms may underpin this phenomenon -a pharmacological sensitisation that is independent of context and a contextually-conditioned sensitisation that depends upon repeated association between the drug and the context in which it is delivered (Balfour 2015).…”
Section: The Role Of Contextual Conditioningmentioning
confidence: 99%
“…1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 These results, when taken together, imply that MPEP attenuates the expression of behavioural responses to nicotine that are conditioned to the context in which nicotine is administered. Balfour (2015) speculated that the increase in extracellular DA, evoked in the nucleus accumbens by nicotine, may play an important role in establishing the motivational salience of conditioned context cues.…”
Section: The Role Of Contextual Conditioningmentioning
confidence: 99%
“…Novel treatments, therefore, need to be able to accommodate these "difficult to treat" smoker populations. While it is clear that nicotine is the principal addictive component of tobacco smoke, studies in humans and with animal models suggest that its addictive properties are not sufficiently potent to explain the powerful addiction to tobacco smoke experienced by a majority of habitual smokers (Caggiula et al 2001;Balfour 2015).…”
RationaleMost habitual smokers find it difficult to quit smoking because they are dependent upon the nicotine present in tobacco smoke. Tobacco dependence is commonly treated pharmacologically using nicotine replacement therapy or drugs, such as varenicline, that target the nicotinic receptor.Relapse rates, however, remain high and there remains a need to develop novel non-nicotinic pharmacotherapies for the dependence that are more effective than existing treatments.
ObjectiveThe purpose of this paper is to review the evidence from preclinical and clinical studies that drugs that antagonise the metabotropic glutamate receptor 5 (mGluR5) in the brain are likely to be efficacious as treatments for tobacco dependence.
ResultsImaging studies reveal that chronic exposure to tobacco smoke reduces the density of mGluR5s in human brain. Preclinical results demonstrate that negative allosteric modulators (NAMs) at mGluR5 attenuate both nicotine self-administration and the reinstatement of responding evoked by exposure to conditioned cues paired with nicotine delivery. They also attenuate the effects of nicotine on brain dopamine pathways implicated in addiction.
ConclusionsAlthough mGluR5 NAMs attenuate most of the key facets of nicotine dependence they potentiate the symptoms of nicotine withdrawal. This may limit their value as smoking cessation aids. The NAMs that have been employed most widely in preclinical studies of nicotine dependence have too many "off target" effects to be used clinically. However newer mGluR5 NAMs have been developed for clinical use in other indications. Future studies will determine if these agents can also be used effectively and safely to treat tobacco dependence.
“…There is abundant evidence that the reinforcing properties of nicotine depend upon stimulation of DA neurones in the ventral tegmental area that project to the nucleus accumbens (see Balfour 2015 for review). The ability of psychostimulant drugs, such as nicotine, to serve as reinforcers in selfadministration experiments have been particularly related to increased DA release in the shell subdivision of the accumbens.…”
Section: The Role Of Mglur5 Receptors In the Neural Responses To Nicomentioning
confidence: 99%
“…Thus, it seems likely that, while the addiction to tobacco smoke requires the presence of nicotine, other components of tobacco smoke also contribute significantly to the addiction (Balfour 2015). Although there are a number of chemical components within tobacco smoke that may enhance the addictive properties of nicotine, much attention has been focused on the role of sensory stimuli within the smoke in the development of dependence.…”
Section: Mglur5 Receptors and Models Of Relapsementioning
confidence: 99%
“…Repetitive non-contingent daily injections of nicotine result in sensitisation of the locomotor stimulation evoked by the drug. However, there is evidence that two mechanisms may underpin this phenomenon -a pharmacological sensitisation that is independent of context and a contextually-conditioned sensitisation that depends upon repeated association between the drug and the context in which it is delivered (Balfour 2015).…”
Section: The Role Of Contextual Conditioningmentioning
confidence: 99%
“…1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 These results, when taken together, imply that MPEP attenuates the expression of behavioural responses to nicotine that are conditioned to the context in which nicotine is administered. Balfour (2015) speculated that the increase in extracellular DA, evoked in the nucleus accumbens by nicotine, may play an important role in establishing the motivational salience of conditioned context cues.…”
Section: The Role Of Contextual Conditioningmentioning
confidence: 99%
“…Novel treatments, therefore, need to be able to accommodate these "difficult to treat" smoker populations. While it is clear that nicotine is the principal addictive component of tobacco smoke, studies in humans and with animal models suggest that its addictive properties are not sufficiently potent to explain the powerful addiction to tobacco smoke experienced by a majority of habitual smokers (Caggiula et al 2001;Balfour 2015).…”
RationaleMost habitual smokers find it difficult to quit smoking because they are dependent upon the nicotine present in tobacco smoke. Tobacco dependence is commonly treated pharmacologically using nicotine replacement therapy or drugs, such as varenicline, that target the nicotinic receptor.Relapse rates, however, remain high and there remains a need to develop novel non-nicotinic pharmacotherapies for the dependence that are more effective than existing treatments.
ObjectiveThe purpose of this paper is to review the evidence from preclinical and clinical studies that drugs that antagonise the metabotropic glutamate receptor 5 (mGluR5) in the brain are likely to be efficacious as treatments for tobacco dependence.
ResultsImaging studies reveal that chronic exposure to tobacco smoke reduces the density of mGluR5s in human brain. Preclinical results demonstrate that negative allosteric modulators (NAMs) at mGluR5 attenuate both nicotine self-administration and the reinstatement of responding evoked by exposure to conditioned cues paired with nicotine delivery. They also attenuate the effects of nicotine on brain dopamine pathways implicated in addiction.
ConclusionsAlthough mGluR5 NAMs attenuate most of the key facets of nicotine dependence they potentiate the symptoms of nicotine withdrawal. This may limit their value as smoking cessation aids. The NAMs that have been employed most widely in preclinical studies of nicotine dependence have too many "off target" effects to be used clinically. However newer mGluR5 NAMs have been developed for clinical use in other indications. Future studies will determine if these agents can also be used effectively and safely to treat tobacco dependence.
The motivation to seek out and consume rewards has evolutionarily been driven by the urge to fulfill physiological needs. However in a modern society dominated more by plenty than scarcity, we tend to think of motivation as fueled by the search for pleasure. Here, we argue that two separate but interconnected subcortical and unconscious processes direct motivation: "wanting" and "liking." These two psychological and neuronal processes and their related brain structures typically work together, but can become dissociated, particularly in cases of addiction. In drug addiction, for example, repeated consumption of addictive drugs sensitizes the mesolimbic dopamine system, the primary component of the "wanting" system, resulting in excessive "wanting" for drugs and their cues. This sensitizing process is long-lasting and occurs independently of the "liking" system, which typically remains unchanged or may develop a blunted pleasure response to the drug. The result is excessive drug-taking despite minimal pleasure and intense cue-triggered craving that may promote relapse long after detoxification. Here, we describe the roles of "liking" and "wanting" in general motivation and review recent evidence for a dissociation of "liking" and "wanting" in drug addiction, known as the incentive sensitization theory (Robinson and Berridge 1993). We also make the case that sensitization of the "wanting" system and the resulting dissociation of "liking" and "wanting" occurs in both gambling disorder and food addiction.
Nicotine dependence is a chronic, relapsing disorder with complex biological mechanisms underlying the motivational basis for this behavior. Although more than 70 % of current smokers express a desire to quit, most relapse within one year, underscoring the need for novel treatments. A key focus of translational research models addressing nicotine dependence has been on cross-validation of human and animal models in order to improve the predictive value of medication screening paradigms. In this chapter, we review several lines of research highlighting the utility of cross-validation models in elucidating the biological underpinnings of nicotine reward and reinforcement, identifying factors which may influence individual response to treatment, and facilitating rapid translation of findings to practice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.